Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Julien Fittler

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cells|September 12, 2020
Nucleic Acid-Based Approaches for Tumor TherapySimone Hager, Frederic Julien Fittler, Ernst Wagner, et al.
International Journal of Molecular Sciences|April 3, 2021
Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 CellsMonika Bednarczyk, Carolina Medina-Montano, Frederic Julien Fittler, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cells|September 12, 2020
Nucleic Acid-Based Approaches for Tumor TherapySimone Hager, Frederic Julien Fittler, Ernst Wagner, et al.
International Journal of Molecular Sciences|April 3, 2021
Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 CellsMonika Bednarczyk, Carolina Medina-Montano, Frederic Julien Fittler, et al.
Pageof 1